US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

60.77

+0.19010.31%

Post-market: 60.850.0808+0.13%19:30 EDT

Volume:17.10K

Turnover:1.04M

Market Cap:283.79M

PE:19.88

High:61.84

Open:61.35

Low:60.77

Close:60.58

52wk High:64.10

52wk Low:39.36

Shares:4.67M

Float Shares:4.67M

Volume Ratio:0.82

T/O Rate:0.37%

Dividend:1.53

Dividend Rate:2.51%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)

Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Sector Update: Healthcare Stocks Edge Higher Premarket Monday

MT Newswires Live

Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%

THOMSON REUTERS

Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

CervoMed Q2 Net Loss Lower than Estimates as Costs Drop

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss

THOMSON REUTERS

Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year

Axsome Therapeutics Q2 Net Income USD -51.314 Million

Axsome Therapeutics Q2 EPS USD -0.99

THOMSON REUTERS

Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million

THOMSON REUTERS

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS

Roivant Sciences Ltd : Citigroup Raises Target Price to $46 from $42

THOMSON REUTERS

BeOne Medicines partners with Revolution Medicines for clinical development

BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal

Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets

THOMSON REUTERS

Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor

THOMSON REUTERS

Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/PTH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":60.7692,"timestamp":1789156800000,"preClose":60.5791,"halted":0,"volume":17099,"hourTrading":{"tag":"盘后","latestPrice":60.85,"preClose":60.7692,"latestTime":"19:30 EDT","volume":14,"amount":850.1752,"timestamp":1789169406061,"change":0.0808,"changeRate":0.00133,"amplitude":0},"delay":0,"changeRate":0.0031380459597452103,"floatShares":4670000,"shares":4670000,"eps":3.057033,"marketStatus":"Market Closed","change":0.1901,"latestTime":"09-11 16:00:00 EDT","open":61.35,"high":61.84,"low":60.7692,"amount":1043194.053732,"amplitude":0.017676,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":60.5791,"sharesOutstanding":2480000,"nav":60.58293,"aum":283728993.67,"dividendRate":0.025121,"bidAskSpread":0.001903,"postHourTrading":{"tag":"盘后","latestPrice":60.85,"preClose":60.7692,"latestTime":"19:30 EDT","volume":14,"amount":850.1752,"timestamp":1789169406061,"change":0.0808,"changeRate":0.00133,"amplitude":0},"volumeRatio":0.8220198874200522,"impliedVol":0.1499,"impliedVolPercentile":0.741},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4670000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8220198874200522,"shares":4670000,"dividePrice":1.5266,"high":61.84,"amplitude":0.017676,"preClose":60.5791,"low":60.7692,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":60.7692,"eps":3.057033,"divideRate":0.025121,"volume":17099,"delay":0,"ttmEps":3.057033,"open":61.35,"prevYearClose":49.701,"prevWeekClose":61.1284,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":61.3641,"twentyDayClose":59.8872,"sixtyDayClose":51.8126},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658584679","title":"Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658584679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658584679?lang=en_us&edition=fundamental","pubTime":"2026-08-11 00:50","pubTimestamp":1786380608,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Heron Therapeutics (HRTX), Aquestive Therapeutics (AQST) and Axso...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heron-therapeutics-hrtx-aquestive-therapeutics-aqst-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-heron-therapeutics-hrtx-aquestive-therapeutics-aqst-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","HRTX","BK4007","AXSM","LABU","AQST","BK4505","LU0128526141.USD","LU2324357040.USD","HCSG","BK4139","LU0029874061.USD","BK4581","PTH","XLV","BK4588","BK4585","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658393127","title":"Axsome Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658393127","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658393127?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:30","pubTimestamp":1786368646,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryAxsome Therapeutics, Inc.AXSM.OQreported a quarterly adjusted loss of 99 cents per share for the quarter ended","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N447157:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2324357040.USD","BK4505","BK4007","PTH","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658155931","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2658155931","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658155931?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:18","pubTimestamp":1786367886,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) slightly advancing and the iShares Biotechnology ETF (IBB) up 0.5%.Sionna Therapeu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","AXSM","BK4588","BK4585","BK4139","BK4137","LU0128526141.USD","BK4121","ABCL","SION","LU2324357040.USD","IBB","PTH","BK4505","XLV","HCSG","LU0029874061.USD","BK4535","LABU","BK4581","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658293618","title":"Axsome Therapeutics Shares Reverse Course Premarket; Last up 2.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658293618","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658293618?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:20","pubTimestamp":1786364445,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4007","LU2324357040.USD","BK4505","BK4585","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658593507","title":"Heron Therapeutics Q2 Revenue Rises on Acute Care Growth, Withdraws 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2658593507","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658593507?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:08","pubTimestamp":1786363720,"startTime":"0","endTime":"0","summary":"Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlookOverviewUS biotechnology firm's Q2 net revenue rose 1.3% yr/yr to $37.7 mlnCompany withdrew full-year 2026 guidance citi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","BK4505","HRTX","LU2324357040.USD","BIAF","BK4139","PTH","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658354779","title":"Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658354779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658354779?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xencor (XNCR), Revolution Medicines (RVMD) and Roiva...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","LABU","XNCR","IE00B2B36J28.USD","BK4585","XBI","RVMD","HCSG","LU0320765992.SGD","BBH","XLV","LU0109394709.USD","IE00BFTCPJ56.SGD","IDNA","BK4139","CANC","LU0128526141.USD","IE00B4R5TH58.HKD","BK4581","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009354923.USD","PTH","BK4137","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658443933","title":"CervoMed Q2 Net Loss Lower than Estimates as Costs Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2658443933","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658443933?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:38","pubTimestamp":1786361915,"startTime":"0","endTime":"0","summary":"CervoMed Q2 net loss lower than estimates as costs dropOverviewUS biotech developer's Q2 net loss was lower than analyst expectationsCompany completed $20.5 mln equity financings, extending cash runwa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470AO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","CRVO","LU2324357040.USD","AXSM","PTH","BK4505","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938415","title":"Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938415","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938415?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:10","pubTimestamp":1786360249,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics Q2 revenue rises on AUVELITY growthOverviewUS biopharmaceutical firm's Q2 revenue grew 46% yr/yr but missed analyst expectationsNet loss for Q2 widened slightly compared to last ye","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N44709M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","TMCI","BK4585","LU1559883803.SGD","BK4139","LU2324357040.USD","GYRE","BK4539","BK4007","BK4505","LU0566484027.USD","AXSM","PTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658893819","title":"Axsome Therapeutics Shares Down 8.4% Premarket After Q2 Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658893819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658893819?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:08","pubTimestamp":1786360128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4585","BK4505","LU2324357040.USD","BK4007","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658381179","title":"Axsome Q2 FY26 Net Loss Widens to $51.3 Million; Net Product Revenue Climbs 46% to $218.4 Million Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2658381179","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658381179?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:08","pubTimestamp":1786360116,"startTime":"0","endTime":"0","summary":"Axsome Q2 FY26 net loss widens to $51.3 million; net product revenue climbs 46% to $218.4 million year over yearAxsome posted 2Q 2026 net product revenue of $218.4 million, up 46% year over year.Net l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4b4sNn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","BK4585","LU2324357040.USD","AXSM","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658383679","title":"Axsome Therapeutics Q2 Net Income USD -51.314 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658383679","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658383679?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:01","pubTimestamp":1786359662,"startTime":"0","endTime":"0","summary":"BRIEF-Axsome Therapeutics Q2 Net Income USD -51.314 MillionAug 10 (Reuters) - Axsome Therapeutics Q2 pretax profit USD -51.186 million.Q2 operating income USD -49.646 millionQ2 operating expenses USD 268.021 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AXSM","BK4505","LU2324357040.USD","PTH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658938554","title":"Axsome Therapeutics Q2 EPS USD -0.99","url":"https://stock-news.laohu8.com/highlight/detail?id=2658938554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658938554?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4007","BK4585","LU2324357040.USD","PTH","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658777980","title":"Axsome Therapeutics Q2 Operating Expenses USD 268.021 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658777980","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658777980?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLX24BRB4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AXSM","BK4007","BK4505","BK4585","LU2324357040.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658798005","title":"Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2658798005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658798005?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA9MN6XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","LU2324357040.USD","PTH","BK4007","AXSM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658987522","title":"Roivant Sciences Ltd : Citigroup Raises Target Price to $46 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2658987522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658987522?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:15","pubTimestamp":1786356924,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470K6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTH","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658110987","title":"BeOne Medicines partners with Revolution Medicines for clinical development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658110987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658110987?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:15","pubTimestamp":1786356922,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) and Revolution Medicines (RVMD) announced a multi-part collaboration including: a clinical collaboration to evaluate drug com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-partners-with-revolution-medicines-for-clinical-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-partners-with-revolution-medicines-for-clinical-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IDNA","IE0009354923.USD","BK4588","LU0320765992.SGD","BK4585","IE0002141913.USD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4526","ONC","PTH","RVMD","IE00B4R5TH58.HKD","CANC","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982220","title":"BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982220","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982220?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:01","pubTimestamp":1786356092,"startTime":"0","endTime":"0","summary":"BeOne Medicines teams with Revolution Medicines on RAS cancer drug development, Asia rights dealBeOne Medicines AG entered a multi-part collaboration with Revolution Medicines covering clinical develo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9VYymL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","IE0002141913.USD","BBH","LU0889565916.HKD","688235","IE0009354923.USD","IE0009355771.USD","BK0239","IE00BJJMRZ35.SGD","RVMD","IE00B2B36J28.USD","CANC","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","LU0320765992.SGD","PTH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982475","title":"Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982475?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","LU0109394709.USD","RVMD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BBH","BK0239","IE00B4R5TH58.HKD","688235","CANC","IE0009354923.USD","IDNA","IE00B2B36J28.USD","BK4139","IE0009355771.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982449","title":"Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982449?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","LU0109394709.USD","RVMD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BBH","BK0239","IE00B4R5TH58.HKD","688235","CANC","IE0009354923.USD","IDNA","IE00B2B36J28.USD","BK4139","IE0009355771.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658296982","title":"Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2658296982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658296982?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","IE0009355771.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0009354923.USD","LU0320765992.SGD","BBH","IE00BJJMRZ35.SGD","PTH","LU0109394709.USD","IE00B4R5TH58.HKD","688235","BK4139","IDNA","CANC","BK0239","RVMD","IE00BJT1NW94.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}